SGMO will retrace slightly before its FDA approval, still trading above 100 EMA, MFI/RSI cooling off.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
